By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Signal Genetics LLC 

667 Madison Avenue
14th Floor
New York  New York  10065  U.S.A.
Phone: 212-486-0040 Fax: 212-319-3328


SEARCH JOBS


Industry
Diagnostics






Company News
Signal Genetics LLC (SGNL) To Present At The Aegis Capital Corp. 2014 Healthcare & Technology Conference 9/8/2014 10:22:16 AM
Signal Genetics LLC (SGNL) Appoints Michael C. Cerio Senior Vice President Of Commercial Strategy And Business Development 8/11/2014 8:10:12 AM
Signal Genetics LLC (SGNL) Obtains New York State Approval For MyPRS® Multiple Myeloma Prognostic Test 6/30/2014 12:05:54 PM
Signal Genetics LLC (SGNL) Announces Closing Of Initial Public Offering Of 850,000 Shares Of Common Stock 6/24/2014 8:32:36 AM
New York's Signal Genetics LLC (SGNL) Prices IPO At $10 A Share 6/18/2014 7:40:38 AM
Med BioGene Announces Settlement Agreement for the Dismissal of Litigation With Signal Genetics LLC and Respira Health LLC 8/22/2013 7:07:06 AM
Med BioGene Update to Ongoing Signal Genetics LLC and Respira Lawsuit 2/25/2013 8:04:39 AM
Signal Genetics LLC to Buy ChipDX LLC to Gain Cancer Diagnostics 2/2/2012 10:35:19 AM
Signal Genetics LLC Announces Publication of Meta-Analysis of its Colon Cancer Test-Previstage(TM) GCC Confirming Prognostic Capabilities in Patients with Colon Cancer 1/24/2012 9:20:59 AM
Signal Genetics LLC Announces Launch of Next Generation Genetic Multiple Myeloma Predictive Testing Product-MyPRS Plus(TM) 12/9/2011 10:45:21 AM
12
//-->